See more : Tricon Residential Inc. (TCN.TO) Income Statement Analysis – Financial Results
Complete financial analysis of Danaher Corporation (DHR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Danaher Corporation, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
You may be interested
- Papaya Growth Opportunity Corp. I (PPYA) Income Statement Analysis – Financial Results
- La Française des Jeux Société anonyme (FDJ.PA) Income Statement Analysis – Financial Results
- Tokyo Tatemono Co., Ltd. (TYTMF) Income Statement Analysis – Financial Results
- Bayview Acquisition Corp Class A Ordinary Shares (BAYA) Income Statement Analysis – Financial Results
- Sahathai Printing & Packaging Public Company Limited (STP.BK) Income Statement Analysis – Financial Results
Danaher Corporation (DHR)
About Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 23.89B | 31.47B | 29.45B | 22.28B | 17.91B | 19.89B | 18.33B | 16.88B | 20.56B | 19.91B | 19.12B | 18.26B | 16.09B | 13.20B | 11.18B | 12.70B | 11.03B | 9.60B | 7.98B | 6.89B | 5.29B | 4.58B | 3.78B | 3.78B | 3.20B | 2.91B | 2.05B | 1.81B | 1.49B | 1.29B | 1.07B | 949.00M | 831.60M | 840.00M | 749.10M | 714.60M | 615.00M | 446.00M | 298.00M |
| Cost of Revenue | 9.86B | 12.52B | 11.50B | 9.81B | 7.93B | 8.79B | 8.14B | 7.55B | 9.80B | 9.47B | 9.16B | 8.85B | 7.91B | 6.58B | 5.90B | 6.76B | 5.99B | 5.35B | 4.54B | 4.00B | 3.15B | 2.79B | 2.34B | 2.17B | 1.83B | 1.71B | 1.31B | 1.17B | 981.10M | 889.70M | 753.00M | 670.30M | 601.90M | 573.30M | 499.10M | 462.00M | 406.40M | 342.40M | 239.70M |
| Gross Profit | 14.03B | 18.95B | 17.95B | 12.48B | 9.98B | 11.11B | 10.19B | 9.33B | 10.76B | 10.44B | 9.96B | 9.41B | 8.18B | 6.63B | 5.28B | 5.94B | 5.04B | 4.24B | 3.45B | 2.89B | 2.14B | 1.79B | 1.44B | 1.61B | 1.36B | 1.20B | 744.60M | 640.70M | 505.70M | 399.00M | 314.10M | 278.70M | 229.70M | 266.70M | 250.00M | 252.60M | 208.60M | 103.60M | 58.30M |
| Gross Profit Ratio | 58.74% | 60.21% | 60.95% | 55.98% | 55.74% | 55.83% | 55.61% | 55.29% | 52.34% | 52.44% | 52.08% | 51.56% | 50.82% | 50.19% | 47.21% | 46.78% | 45.72% | 44.22% | 43.15% | 41.99% | 40.41% | 39.02% | 38.19% | 42.66% | 42.62% | 41.15% | 36.30% | 35.36% | 34.01% | 30.96% | 29.43% | 29.37% | 27.62% | 31.75% | 33.37% | 35.35% | 33.92% | 23.23% | 19.56% |
| Research & Development | 1.50B | 1.75B | 1.74B | 1.35B | 1.13B | 1.23B | 1.13B | 975.10M | 1.24B | 1.31B | 1.25B | 1.14B | 1.02B | 809.48M | 632.65M | 725.44M | 601.42M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 7.25B | 8.52B | 8.20B | 6.90B | 5.59B | 6.47B | 6.04B | 5.61B | 6.05B | 5.70B | 5.43B | 5.18B | 4.61B | 3.67B | 3.19B | 3.35B | 2.71B | 2.74B | 2.18B | 1.80B | 1.32B | 1.09B | 872.68M | 909.90M | 778.40M | 722.10M | 401.60M | 345.90M | 266.90M | 208.50M | 180.20M | 180.60M | 161.60M | 165.50M | 136.90M | 130.40M | 110.60M | 61.30M | 31.60M |
| Other Expenses | 0.00 | -226.00M | 547.00M | 39.00M | 12.00M | 37.20M | 72.80M | 223.40M | 12.40M | 156.50M | 0.00 | 0.00 | 0.00 | 0.00 | -85.12M | 0.00 | -14.34M | -16.38M | 4.60M | -8.14M | -22.50M | 2.78B | 0.00 | 149.72M | 126.40M | 108.70M | 76.10M | 68.60M | 58.50M | 44.60M | 40.90M | 37.10M | 33.20M | 25.60M | 19.10M | 17.60M | 13.50M | 9.30M | 6.80M |
| Operating Expenses | 8.83B | 10.26B | 10.49B | 8.24B | 6.71B | 7.70B | 7.17B | 6.58B | 7.29B | 7.01B | 6.68B | 6.32B | 5.56B | 4.48B | 3.74B | 4.07B | 3.30B | 2.73B | 2.18B | 1.79B | 1.29B | 1.09B | 872.68M | 1.06B | 904.80M | 830.80M | 477.70M | 414.50M | 325.40M | 253.10M | 221.10M | 217.70M | 194.80M | 191.10M | 156.00M | 148.00M | 124.10M | 70.60M | 38.40M |
| Cost & Expenses | 18.69B | 22.78B | 21.99B | 18.05B | 14.64B | 16.49B | 15.31B | 14.13B | 17.09B | 16.48B | 15.84B | 15.17B | 13.47B | 11.06B | 9.64B | 10.83B | 9.29B | 8.08B | 6.72B | 5.78B | 4.45B | 3.88B | 3.21B | 3.23B | 2.74B | 2.54B | 1.78B | 1.59B | 1.31B | 1.14B | 974.10M | 888.00M | 796.70M | 764.40M | 655.10M | 610.00M | 530.50M | 413.00M | 278.10M |
| Interest Income | 303.00M | 41.00M | 11.00M | 71.00M | 139.00M | 9.20M | 7.50M | 200.00K | 5.30M | 16.70M | 5.70M | 3.20M | 5.15M | 6.07M | 5.03M | 10.00M | 6.09M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 286.00M | 211.00M | 238.00M | 275.00M | 108.60M | 157.40M | 162.70M | 184.40M | 162.80M | 122.70M | 145.90M | 157.50M | 141.64M | 120.78M | 122.66M | 130.17M | 109.70M | 0.00 | 0.00 | 0.00 | 0.00 | 43.65M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 2.17B | 2.13B | 2.17B | 1.78B | 1.19B | 1.18B | 1.24B | 1.13B | 1.05B | 938.50M | 895.00M | 839.80M | 634.93M | 397.08M | 341.59M | 339.29M | 268.49M | 217.19M | 176.97M | 156.13M | 133.44M | 129.57M | 178.39M | 149.72M | 126.40M | 108.70M | 76.10M | 68.60M | 58.50M | 44.60M | 40.90M | 37.10M | 33.20M | 25.60M | 19.10M | 17.60M | 13.50M | 9.30M | 6.80M |
| EBITDA | 7.50B | 9.71B | 10.01B | 6.59B | 4.60B | 4.28B | 4.34B | 4.03B | 3.21B | 4.54B | 4.61B | 4.01B | 3.22B | 2.86B | 1.89B | 2.22B | 2.02B | 1.74B | 1.46B | 1.26B | 979.43M | 824.41M | 750.13M | 701.87M | 584.40M | 498.70M | 343.00M | 294.80M | 238.80M | 190.50M | 133.90M | 98.10M | 68.10M | 101.20M | 113.10M | 122.20M | 98.00M | 42.30M | 26.70M |
| EBITDA Ratio | 31.39% | 34.08% | 34.29% | 27.45% | 25.74% | 23.92% | 23.68% | 24.30% | 22.07% | 22.81% | 21.84% | 21.95% | 20.24% | 21.67% | 16.89% | 17.47% | 18.09% | 17.91% | 18.11% | 18.19% | 18.08% | 17.87% | 21.68% | 18.58% | 18.65% | 17.74% | 16.72% | 16.27% | 16.06% | 14.78% | 11.76% | 9.65% | 7.49% | 11.42% | 14.12% | 16.95% | 15.63% | 7.69% | 6.68% |
| Operating Income | 5.20B | 8.69B | 7.47B | 4.23B | 3.27B | 3.40B | 3.02B | 2.75B | 3.47B | 3.43B | 3.27B | 3.17B | 2.62B | 2.17B | 1.54B | 1.87B | 1.74B | 1.52B | 1.26B | 1.11B | 846.00M | 701.12M | 502.01M | 552.15M | 458.00M | 366.80M | 266.90M | 226.20M | 180.30M | 145.90M | 93.00M | 61.00M | 34.90M | 75.60M | 94.00M | 104.60M | 84.50M | 33.00M | 19.90M |
| Operating Income Ratio | 21.77% | 27.61% | 25.35% | 18.99% | 18.25% | 17.11% | 16.48% | 16.29% | 16.87% | 17.23% | 17.13% | 17.33% | 16.27% | 16.41% | 13.79% | 14.72% | 15.79% | 15.82% | 15.84% | 16.04% | 15.98% | 15.32% | 13.27% | 14.62% | 14.33% | 12.60% | 13.01% | 12.48% | 12.13% | 11.32% | 8.72% | 6.43% | 4.20% | 9.00% | 12.55% | 14.64% | 13.74% | 7.40% | 6.68% |
| Total Other Income/Expenses | -158.00M | -390.00M | 133.00M | 264.00M | 35.90M | 237.80M | -82.40M | -123.90M | -122.80M | 50.50M | 291.10M | -154.30M | -289.95M | 176.33M | -117.62M | -120.17M | -103.61M | -89.15M | -13.13M | -47.42M | -48.96M | -43.65M | -25.75M | -29.23M | -28.50M | -49.80M | -12.90M | -16.80M | -7.20M | -9.30M | -2.00M | -4.30M | -8.60M | -13.50M | -14.90M | -31.60M | -41.10M | -15.20M | -5.80M |
| Income Before Tax | 5.04B | 8.29B | 7.60B | 4.50B | 3.31B | 3.29B | 2.94B | 2.61B | 3.32B | 3.48B | 3.57B | 3.01B | 2.45B | 2.34B | 1.42B | 1.75B | 1.64B | 1.45B | 1.23B | 1.06B | 797.04M | 657.47M | 476.26M | 522.92M | 429.50M | 301.10M | 253.80M | 209.80M | 173.10M | 136.60M | 91.00M | 56.70M | 26.30M | 62.10M | 79.10M | 73.00M | 43.40M | 17.80M | 14.10M |
| Income Before Tax Ratio | 21.11% | 26.35% | 25.80% | 20.17% | 18.45% | 16.55% | 16.03% | 15.47% | 16.16% | 17.48% | 18.65% | 16.49% | 15.21% | 17.74% | 12.74% | 13.78% | 14.85% | 15.07% | 15.46% | 15.35% | 15.06% | 14.36% | 12.59% | 13.84% | 13.43% | 10.35% | 12.37% | 11.58% | 11.64% | 10.60% | 8.53% | 5.97% | 3.16% | 7.39% | 10.56% | 10.22% | 7.06% | 3.99% | 4.73% |
| Income Tax Expense | 823.00M | 1.08B | 1.25B | 849.00M | 873.00M | 641.90M | 469.00M | 457.90M | 725.30M | 883.40M | 871.00M | 711.50M | 512.56M | 549.71M | 273.15M | 431.68M | 423.10M | 324.14M | 336.64M | 311.72M | 260.20M | 223.33M | 178.60M | 198.71M | 167.90M | 118.20M | 99.00M | 81.80M | 67.30M | 54.90M | 37.30M | 25.10M | 13.00M | 26.40M | 32.00M | 33.00M | 22.90M | 9.10M | 8.50M |
| Net Income | 4.76B | 7.21B | 6.43B | 3.65B | 3.01B | 2.65B | 2.49B | 2.55B | 3.36B | 2.60B | 2.70B | 2.39B | 2.17B | 1.79B | 1.15B | 1.32B | 1.37B | 1.12B | 897.80M | 746.00M | 536.83M | 290.39M | 297.67M | 324.21M | 261.60M | 182.90M | 154.80M | 207.80M | 108.40M | 81.70M | 17.70M | 31.60M | 13.30M | 35.70M | 61.10M | 39.00M | 20.10M | 8.70M | 5.60M |
| Net Income Ratio | 19.94% | 22.91% | 21.84% | 16.36% | 16.80% | 13.33% | 13.60% | 15.13% | 16.33% | 13.05% | 14.10% | 13.10% | 13.50% | 13.58% | 10.30% | 10.38% | 12.42% | 11.69% | 11.24% | 10.83% | 10.14% | 6.34% | 7.87% | 8.58% | 8.18% | 6.29% | 7.55% | 11.47% | 7.29% | 6.34% | 1.66% | 3.33% | 1.60% | 4.25% | 8.16% | 5.46% | 3.27% | 1.95% | 1.88% |
| EPS | 6.44 | 9.80 | 8.77 | 4.97 | 3.48 | 3.78 | 3.58 | 3.69 | 4.81 | 3.70 | 3.87 | 3.45 | 3.21 | 2.74 | 1.80 | 2.07 | 2.20 | 1.82 | 1.46 | 1.21 | 0.88 | 0.48 | 0.52 | 0.57 | 0.46 | 0.34 | 0.33 | 0.44 | 0.23 | 0.09 | 0.04 | 0.07 | 0.03 | 0.09 | 0.16 | 0.10 | 0.06 | 0.03 | 0.02 |
| EPS Diluted | 6.38 | 9.64 | 8.61 | 4.89 | 3.43 | 3.73 | 3.53 | 3.65 | 4.74 | 3.63 | 3.80 | 3.36 | 3.11 | 2.64 | 1.73 | 1.98 | 2.10 | 1.74 | 1.38 | 1.15 | 0.84 | 0.47 | 0.50 | 0.56 | 0.45 | 0.33 | 0.32 | 0.43 | 0.23 | 0.09 | 0.04 | 0.07 | 0.03 | 0.09 | 0.16 | 0.10 | 0.05 | 0.03 | 0.02 |
| Weighted Avg Shares Out | 736.50M | 725.10M | 714.60M | 706.20M | 715.00M | 700.60M | 695.80M | 691.20M | 698.10M | 702.20M | 696.00M | 693.40M | 676.20M | 653.20M | 641.53M | 638.72M | 622.45M | 615.97M | 617.81M | 617.93M | 613.58M | 600.90M | 574.52M | 569.88M | 567.33M | 559.26M | 571.52M | 532.27M | 471.30M | 933.23M | 442.50M | 451.43M | 443.33M | 420.00M | 376.00M | 380.49M | 365.45M | 316.36M | 320.00M |
| Weighted Avg Shares Out (Dil) | 743.10M | 737.10M | 736.80M | 718.70M | 725.50M | 710.20M | 706.10M | 699.80M | 708.50M | 716.10M | 711.00M | 713.10M | 701.20M | 683.30M | 671.48M | 671.73M | 658.92M | 650.50M | 655.97M | 655.40M | 646.28M | 633.93M | 607.39M | 582.00M | 584.36M | 575.95M | 589.38M | 544.65M | 476.48M | 933.23M | 442.50M | 451.43M | 443.33M | 420.00M | 376.00M | 390.00M | 382.86M | 348.00M | 320.00M |
Curious about Danaher (DHR) Q1 Performance? Explore Wall Street Estimates for Key Metrics
Evaluate the expected performance of Danaher (DHR) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Suddenly, There's An Alternative - The Important Case For Wide Moat Dividend Stocks
Short-term bonds currently yield more than stocks, indicating a shift in the investment environment. Investors should focus on companies with healthy balance sheets, pricing power, and that are trading below their fair value. We suggest several favorite wide-moat dividend businesses.
Reasons Why Danaher (DHR) Should be in Your Portfolio Now
Danaher (DHR) is set to benefit from strength across its businesses, acquired assets and shareholder-friendly policies.
Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for April 2024
Healthcare's impact on the economy cannot be overstated. According to the American Medical Association, the U.S. spends more than $4 trillion a year on healthcare, which works out to nearly $13,000 per person.
The Ultimate 5: Unveiling My All-Time Favorite Dividend Growth Investments
Renowned psychologist Daniel Kahneman, known for challenging traditional economic assumptions of rationality, passed away at the age of 90. Kahneman's work on human decision-making influenced various fields beyond finance, such as organ donation programs and infrastructure project planning. One of...
Here's Why Danaher (DHR) Gained But Lagged the Market Today
In the closing of the recent trading day, Danaher (DHR) stood at $244.28, denoting a +0.98% change from the preceding trading day.
Investors Heavily Search Danaher Corporation (DHR): Here is What You Need to Know
Danaher (DHR) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Danaher (DHR) Suffers a Larger Drop Than the General Market: Key Insights
In the closing of the recent trading day, Danaher (DHR) stood at $245.94, denoting a -0.75% change from the preceding trading day.
Danaher (DHR) Rises Yet Lags Behind Market: Some Facts Worth Knowing
Danaher (DHR) reachead $248.77 at the closing of the latest trading day, reflecting a +0.12% change compared to its last close.
Wall Street Analysts See Danaher (DHR) as a Buy: Should You Invest?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Source: https://incomestatements.info
Category: Stock Reports